findmyKOL
Clinical trialNCT07340541RecruitingPhase 2Interventional

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

SponsorUNC Lineberger Comprehensive Cancer CenterEnrollment700Breast CancerEstrogen-receptor-positive Breast CancerHormone Receptor Negative Breast CarcinomaMetastatic Breast CancerTriple Negative Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Rochester, Minnesota, United States

    Karthik Giridhar, MD
    Not, yet, recruiting
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, United States

    Lisa A Carey, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AntiandrogenSERD* + abemaciclibSERD* + everolimusSERD* + everolimus or capecitabine2,2-Dimethyl-4-(chloromethyl)-1,3-dioxa-2-silacyclopentane
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Feb 2026
Primary completion
2 Jun 2031
Completion
2 Jun 2031
Last update posted
20 May 2026
Registered enrollment
700
Registry id
NCT07340541

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.